股票/基金 实时行情 股吧

简称:太龙药业 代码:600222


会计年度:2006-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
口服液146,042,850.4596,270,936.0949,771,914.3634.08
片剂24,769,842.909,571,909.3315,197,933.5761.36
输液31,243,311.9030,154,846.691,088,465.213.48

会计年度:2006-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
口服液59,655,153.0545,274,979.9014,380,173.1524.11
片剂19,589,233.404,417,544.1615,171,689.2477.45
其他55,264,411.2553,356,810.371,907,600.883.45
输液23,421,163.8121,881,723.231,539,440.586.57

会计年度:2005-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
口服液\片剂等251,323,122.92173,186,416.6978,136,706.2331.09

会计年度:2005-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
工业68,420,828.7437,878,874.2430,541,954.5044.64
商业39,228,152.2638,444,258.35783,893.912.00

会计年度:2004-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
口服液等204,039,928.63128,185,915.4175,854,013.2237.18

    7/9 转到